Hypertension :: Novartis’ Exforge, valsartan approved in Europe for patients with high blood pressure
Novartis announced today a positive opinion supporting European Union approval of Exforge? (valsartan/ amlodipine besylate) as a new treatment option for patients with high blood pressure.